Pfizer Weighs Options For OTC Division As Investors Line Up For Purchase
This article was originally published in The Rose Sheet
Executive Summary
While Pfizer considers whether to sell its Consumer Healthcare unit or spin it off to shareholders, potential buyers are placing bids with an eye toward an early June deadline
You may also be interested in...
Colgate on acquisitions
Colgate-Palmolive would "not easily move into" OTC or pharmaceutical categories, CEO Reuben Mark states during June 1 Sanford Bernstein Strategic Decisions Conference. Colgate has been identified as a potential bidder for Pfizer's Consumer Healthcare unit, which in addition to OTCs includes the Listerine oral care brand (1"The Rose Sheet" May 29, 2006, p. 4). Pfizer has expressed it is not interested in selling its brands individually. Separately, Mark notes the firm's advertising spend will be up a record 13%-14% in 2006. Colgate spent $297.1 mil. behind its global brands in the first quarter (2"The Rose Sheet" March 14, 2006, p. 4). The company also placed a record amount behind advertising last year, with spending up 11.5%, exec notes...
Colgate on acquisitions
Colgate-Palmolive would "not easily move into" OTC or pharmaceutical categories, CEO Reuben Mark states during June 1 Sanford Bernstein Strategic Decisions Conference. Colgate has been identified as a potential bidder for Pfizer's Consumer Healthcare unit, which in addition to OTCs includes the Listerine oral care brand (1"The Rose Sheet" May 29, 2006, p. 4). Pfizer has expressed it is not interested in selling its brands individually. Separately, Mark notes the firm's advertising spend will be up a record 13%-14% in 2006. Colgate spent $297.1 mil. behind its global brands in the first quarter (2"The Rose Sheet" March 14, 2006, p. 4). The company also placed a record amount behind advertising last year, with spending up 11.5%, exec notes...
Colgate Snaps Up Tom’s Of Maine In $100 Mil. Deal
Colgate-Palmolive's planned acquisition of natural toothpaste marketer Tom's of Maine will establish the company as the only global oral care firm that serves the health and specialty trade channel, Colgate announced March 21